This Tyra Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Avi Kapoor 6 months ago
NewsInitiationMarketsAnalyst RatingsTrading Ideas
'Top Wall Street analysts changed outlook on top names. See all rating changes incl. upgrades, downgrades & initiations. TYRA rated Buy by analysts.'
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Raymond James analyst Steve Moss initiated coverage on Eagle Bancorp Inc (NASDAQ:EGBN) with a Strong Buy rating and announced a price target of $32. Eagle Bancorp shares closed at $26.61 on Tuesday. See how other analysts view this stock.
- Argus Research initiated coverage on SoFi Technologies Inc (NASDAQ:SOFI) with a Hold rating. SoFi Technologies shares closed at $17.91 on Tuesday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Ananda Baruah initiated coverage on XBP Global Holdings Inc (NASDAQ:XBP) with an Overweight rating and announced a price target of $5. XBP Global shares closed at $2.61 on Tuesday. See how other analysts view this stock.
- TD Cowen analyst Jared Levine initiated coverage on Navan Inc (NASDAQ:NAVN) with a Buy rating and announced a price target of $18. Navan shares closed at $13.85 on Tuesday. See how other analysts view this stock.
- Guggenheim analyst Brad Canino initiated coverage on Tyra Biosciences Inc (NASDAQ:TYRA) with a Buy rating and announced a price target of $54. Tyra Biosciences shares closed at $35.27 on Tuesday. See how other analysts view this stock.
Considering buying TYRA stock? Here’s what analysts think:

Photo via Shutterstock
